Citigroup’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$429K Sell
59,725
-137,282
-70% -$986K ﹤0.01% 3018
2025
Q1
$1.18M Buy
197,007
+52,553
+36% +$315K ﹤0.01% 2447
2024
Q4
$1.13M Buy
144,454
+76,038
+111% +$593K ﹤0.01% 2523
2024
Q3
$739K Buy
68,416
+29,086
+74% +$314K ﹤0.01% 2760
2024
Q2
$332K Sell
39,330
-560,659
-93% -$4.73M ﹤0.01% 2929
2024
Q1
$4.03M Buy
599,989
+478,138
+392% +$3.21M ﹤0.01% 1374
2023
Q4
$716K Buy
121,851
+39,610
+48% +$233K ﹤0.01% 2419
2023
Q3
$802K Buy
82,241
+2,522
+3% +$24.6K ﹤0.01% 2063
2023
Q2
$944K Sell
79,719
-114,871
-59% -$1.36M ﹤0.01% 2286
2023
Q1
$2.1M Buy
194,590
+50,605
+35% +$546K ﹤0.01% 1514
2022
Q4
$1.66M Sell
143,985
-48,287
-25% -$558K ﹤0.01% 1652
2022
Q3
$2.87M Buy
192,272
+57,268
+42% +$855K ﹤0.01% 1391
2022
Q2
$1.22M Buy
135,004
+1,235
+0.9% +$11.1K ﹤0.01% 1932
2022
Q1
$1M Sell
133,769
-8,229
-6% -$61.6K ﹤0.01% 2324
2021
Q4
$1.22M Sell
141,998
-112,681
-44% -$967K ﹤0.01% 2363
2021
Q3
$2.14M Buy
254,679
+216
+0.1% +$1.82K ﹤0.01% 1864
2021
Q2
$2.06M Sell
254,463
-38,851
-13% -$315K ﹤0.01% 2076
2021
Q1
$2.58M Buy
293,314
+253,048
+628% +$2.22M ﹤0.01% 1784
2020
Q4
$452K Buy
+40,266
New +$452K ﹤0.01% 2700
2020
Q1
Sell
-538
Closed -$2K 5083
2019
Q4
$2K Buy
538
+1
+0.2% +$4 ﹤0.01% 4986
2019
Q3
$3K Hold
537
﹤0.01% 4886
2019
Q2
$6K Sell
537
-888
-62% -$9.92K ﹤0.01% 4849
2019
Q1
$25K Buy
1,425
+326
+30% +$5.72K ﹤0.01% 4419
2018
Q4
$19K Buy
1,099
+855
+350% +$14.8K ﹤0.01% 4428
2018
Q3
$10K Buy
244
+117
+92% +$4.8K ﹤0.01% 4714
2018
Q2
$7K Buy
+127
New +$7K ﹤0.01% 4683